TT

Thomas Tom Duthy

Invex Therapeutics Ltd | Executive Director
Dr Duthy has over 18 years of direct financial market and executive level/Board experience with ASX listed companies. He is a Director and Founder of Nemean Group, which provides corporate advisory and investor relations (IR) services in the Life Sciences and Technology sectors. Prior to Sirtex, Tom spent ten years as a leading sell-side Healthcare & Biotechnology analyst at Taylor Collison Limited, focused mainly on small cap companies.

Companies and Roles

Company
Title
Tenure
Since
IXC
IXC
Invex Therapeutics Ltd
  • Executive Director
4yrs, 5mthOct 2020
NTI
NTI
Neurotech International Limited
  • Executive Director
2yrs, 6mthSep 2022
ALA
ALA
Arovella Therapeutics Limited
  • Non-Executive Chairman
  • Non-Executive Director
2yrsMar 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALA
ALA
Arovella Therapeutics Limited
26/11/24N/A4,747,4447,460,736N/A
NTI
NTI
Neurotech International Limited
30/06/24N/A340,00020,000,000N/A
IXC
IXC
Invex Therapeutics Ltd
30/06/24N/A285,661500,000N/A
PAA
PAA
01/02/24N/A250,000166,667N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALA
ALA
Arovella Therapeutics Limited
26/11/24
Issued
620,000$0.185$114,700Director remuneration
ALA
ALA
Arovella Therapeutics Limited
28/03/24
Buy
103,000$0.145$14,935On-market trade
IXC
IXC
Invex Therapeutics Ltd
27/03/24
Transfer
285,661$0.075$21,424Off-market transfer
IXC
IXC
Invex Therapeutics Ltd
27/03/24
Transfer
285,661$0.075$21,424Off-market transfer
NTI
NTI
Neurotech International Limited
29/01/24
Buy
340,000$0.091$30,820On-market trade